• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喜树碱在喜树固定化愈伤组织中的产量提高及其对严重急性呼吸综合征冠状病毒2潜在抗病毒作用的生物信息学洞察。

Enhanced production of camptothecin by immobilized callus of and a bioinformatic insight into its potential antiviral effect against SARS-CoV-2.

作者信息

Mamkulathil Devasia Rajesh, Altaf Mohammad, Fahad Alrefaei Abdulwahed, Manoharadas Salim

机构信息

SCMS Institute of Bioscience and Biotechnology, South Kalamassery, Kochi, Kerala 682033, India.

King Saud University, Central Laboratory, Department of Chemistry, College of Science, P.O. Box. 2454, Riyadh 11451, Saudi Arabia.

出版信息

J King Saud Univ Sci. 2021 Mar;33(2):101344. doi: 10.1016/j.jksus.2021.101344. Epub 2021 Jan 21.

DOI:10.1016/j.jksus.2021.101344
PMID:33531790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826111/
Abstract

Camptothetin (CPT) is a quinoline alkaloid originally isolated from the Chinese tree, . CPT was found to have anticancerous and antiviral properties. Derivatives of natural CPT, including topothecan and irinotecan are used clinically to treat a variety of cancers. Apart from CPT production was also found in the perennial plant In this study we attempted the immobilization of the tissue culture grown callus of for the continuous production of a higher concentration of CPT. As evident from previous studies about the antiviral effects of CPT, we wanted to bioinformatically analyze the binding potential of CPT towards two important proteins of SARS-CoV-2, protease (M) and RNA dependent RNA polymerase (RdRp). Further docking analysis of the CPT against the exterior spike glycoprotein of SARS-CoV-2 was also done to determine their potential interaction. The immobilized callus of produced CPT at a concentration of 420 µg/l by the end of 12 days of growth. The HPLC analysis was done to determine the purity of the CPT synthesized by the immobilization technique. The bioinformatic analysis revealed a higher binding efficiency of CPT and its derivatives, toptecan and irinotecan against M and RdRp. The docking analysis of CPT against the spike glycoprotein of SARS-CoV-2 showed hydrogen bonding with the amino acids at K466 with a bond distance of 2.56A° and K355 with a bond distance of 2.40A°. This finding was of particular importance that other compounds including hydroxychloroquine sulphate, lopinavir and ivermectin could bind with the spike protein only by weak Vander wall bonds and no hydrogen bond formation was noticed. Our studies hence evaluate the efficiency of CPT against SARS-CoV-2, by potentially blocking the interaction of the spike glycoprotein with the angiotensin-converting enzyme 2 (ACE2) receptor found on host cells.

摘要

喜树碱(CPT)是一种喹啉生物碱,最初从中国的一种树中分离出来。人们发现CPT具有抗癌和抗病毒特性。天然CPT的衍生物,包括拓扑替康和伊立替康,在临床上用于治疗多种癌症。除了[未提及的某种植物]外,还在多年生植物[未提及的某种植物]中发现了CPT的产生。在本研究中,我们尝试固定生长在组织培养中的[未提及的某种植物]愈伤组织,以持续生产更高浓度的CPT。从先前关于CPT抗病毒作用的研究中可以明显看出,我们希望通过生物信息学分析CPT与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的两种重要蛋白质,即蛋白酶(M)和RNA依赖性RNA聚合酶(RdRp)的结合潜力。还对CPT与SARS-CoV-2的外部刺突糖蛋白进行了进一步的对接分析,以确定它们潜在的相互作用。在生长12天结束时,固定化的[未提及的某种植物]愈伤组织产生的CPT浓度为420μg/l。通过高效液相色谱(HPLC)分析来确定通过固定化技术合成的CPT的纯度。生物信息学分析显示CPT及其衍生物拓扑替康和伊立替康对M和RdRp具有更高的结合效率。CPT与SARS-CoV-2刺突糖蛋白的对接分析显示,与K466处的氨基酸形成氢键,键距为2.56Å,与K355处的氨基酸形成氢键,键距为2.40Å。这一发现尤为重要,因为包括硫酸羟氯喹、洛匹那韦和伊维菌素在内的其他化合物仅通过弱范德华键与刺突蛋白结合,未观察到氢键形成。因此,我们的研究通过潜在地阻断刺突糖蛋白与宿主细胞上发现的血管紧张素转换酶2(ACE2)受体的相互作用,评估了CPT对SARS-CoV-2的作用效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/a9181ec037a7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/0ae92a147c60/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/a64e48ae1f57/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/a9181ec037a7/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/0ae92a147c60/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/a64e48ae1f57/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a18/7826111/a9181ec037a7/gr3_lrg.jpg

相似文献

1
Enhanced production of camptothecin by immobilized callus of and a bioinformatic insight into its potential antiviral effect against SARS-CoV-2.喜树碱在喜树固定化愈伤组织中的产量提高及其对严重急性呼吸综合征冠状病毒2潜在抗病毒作用的生物信息学洞察。
J King Saud Univ Sci. 2021 Mar;33(2):101344. doi: 10.1016/j.jksus.2021.101344. Epub 2021 Jan 21.
2
Biotechnology for micropropagation and camptothecin production in Ophiorrhiza sp.生物技术在 Ophiorrhiza sp. 中的微繁殖和喜树碱生产中的应用
Appl Microbiol Biotechnol. 2022 Jun;106(11):3851-3877. doi: 10.1007/s00253-022-11941-y. Epub 2022 May 21.
3
Biotechnology of camptothecin production in Nothapodytes nimmoniana, Ophiorrhiza sp. and Camptotheca acuminata.滇榄仁、钩吻和喜树中喜树碱的生物技术生产。
Appl Microbiol Biotechnol. 2021 Dec;105(24):9089-9102. doi: 10.1007/s00253-021-11700-5. Epub 2021 Dec 1.
4
Cell line selection combined with jasmonic acid elicitation enhance camptothecin production in cell suspension cultures of Ophiorrhiza mungos L.细胞系选择结合茉莉酸诱导可提高蛇根草细胞悬浮培养物中喜树碱的产量。
Appl Microbiol Biotechnol. 2017 Jan;101(2):545-558. doi: 10.1007/s00253-016-7808-x. Epub 2016 Aug 31.
5
Nanoelicitor based enhancement of camptothecin production in fungi isolated from Ophiorrhiza mungos.基于纳米引发子增强从钩吻中分离出的真菌中喜树碱的产生。
Biotechnol Prog. 2020 Nov;36(6):e3039. doi: 10.1002/btpr.3039. Epub 2020 Jul 9.
6
Correlation of camptothecin-producing ability and phylogenetic relationship in the genus Ophiorrhiza.在钩吻属中喜树碱产生能力与系统发育关系的相关性。
Planta Med. 2011 May;77(7):759-64. doi: 10.1055/s-0030-1250568. Epub 2010 Nov 23.
7
Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.基于药效团的筛选,以鉴定针对 SARS-CoV2 的 RNA 依赖性 RNA 聚合酶 (RdRp) 的天然来源化合物。
Mol Divers. 2022 Oct;26(5):2613-2629. doi: 10.1007/s11030-021-10358-5. Epub 2022 Jan 9.
8
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.计算机模拟研究阿奇霉素、氯喹和羟氯喹及其对 SARS-CoV-2 感染的潜在作用机制。
Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30.
9
design, retrosynthetic analysis and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2.用于抑制新型冠状病毒刺突糖蛋白与人血管紧张素转换酶2相互作用的杂合抗病毒药物(VTAR-01)的设计、逆合成分析及组合合成
Biol Open. 2020 Oct 15;9(10):bio054056. doi: 10.1242/bio.054056.
10
Optimal harvest-time to maximize the annual camptothecin production by Ophiorrhiza pumila in a plant factory with artificial light.在人工光照的植物工厂中,通过 Ophiorrhiza pumila 实现喜树碱年生产量最大化的最佳收获时间。
J Nat Med. 2022 Sep;76(4):865-872. doi: 10.1007/s11418-022-01634-1. Epub 2022 Jul 5.

引用本文的文献

1
Biotechnological approaches for the production of camptothecin.生物技术生产喜树碱的方法。
Appl Microbiol Biotechnol. 2024 Jun 19;108(1):382. doi: 10.1007/s00253-024-13187-2.
2
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.鉴定 SARS-CoV-2 感染的常见分子特征及其对急性肾损伤和慢性肾脏病的影响。
Front Immunol. 2023 Mar 21;14:961642. doi: 10.3389/fimmu.2023.961642. eCollection 2023.
3
Alkaloids as potential antivirals. A comprehensive review.

本文引用的文献

1
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.伊维菌素与附着在 ACE2 上的 SARS-CoV-2 刺突受体结合域结合。
In Vivo. 2020 Sep-Oct;34(5):3023-3026. doi: 10.21873/invivo.12134.
2
Candidate drugs against SARS-CoV-2 and COVID-19.针对 SARS-CoV-2 和 COVID-19 的候选药物。
Pharmacol Res. 2020 Jul;157:104859. doi: 10.1016/j.phrs.2020.104859. Epub 2020 Apr 29.
3
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
生物碱作为潜在的抗病毒药物。全面综述。
Nat Prod Bioprospect. 2023 Jan 4;13(1):4. doi: 10.1007/s13659-022-00366-9.
4
Multi-Level Biological Network Analysis and Drug Repurposing Based on Leukocyte Transcriptomics in Severe COVID-19: In Silico Systems Biology to Precision Medicine.基于重症 COVID-19 患者白细胞转录组学的多层次生物网络分析与药物再利用:从计算机系统生物学到精准医学
J Pers Med. 2022 Jun 23;12(7):1030. doi: 10.3390/jpm12071030.
5
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.基于方法的 SARS-CoV-2 分子建模、模拟和预测综述。
Chem Rev. 2022 Jul 13;122(13):11287-11368. doi: 10.1021/acs.chemrev.1c00965. Epub 2022 May 20.
6
The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review.天然来源的生物碱作为 COVID-19 的潜在治疗方法:范围综述。
Phytother Res. 2022 Jul;36(7):2686-2709. doi: 10.1002/ptr.7442. Epub 2022 Mar 30.
7
Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics.利用新冠病毒感染模型的下一代测序数据鉴定新型基因特征:聚焦神经新冠及潜在疗法
Front Pharmacol. 2021 Aug 31;12:688227. doi: 10.3389/fphar.2021.688227. eCollection 2021.
8
Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome.综合 RNA 测序数据集的调查揭示了 2019 年冠状病毒病急性呼吸窘迫综合征的枢纽基因和分子机制。
IET Syst Biol. 2021 Aug;15(6):205-218. doi: 10.1049/syb2.12034. Epub 2021 Aug 5.
9
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.一项药物重新利用筛选鉴定出了能够抑制新冠病毒刺突蛋白与血管紧张素转换酶2结合的化合物。
Front Pharmacol. 2021 Jun 14;12:685308. doi: 10.3389/fphar.2021.685308. eCollection 2021.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
4
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.利巴韦林、瑞德西韦、索非布韦、加洛韦和替诺福韦对 SARS-CoV-2 RNA 依赖的 RNA 聚合酶(RdRp)的抑制作用:一项分子对接研究。
Life Sci. 2020 Jul 15;253:117592. doi: 10.1016/j.lfs.2020.117592. Epub 2020 Mar 25.
5
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.预测血管紧张素转化酶 2(ACE2)作为 SARS-CoV-2 受体的利用能力。
Microbes Infect. 2020 May-Jun;22(4-5):221-225. doi: 10.1016/j.micinf.2020.03.003. Epub 2020 Mar 19.
6
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
7
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.新型冠状病毒的出现:严重急性呼吸系统综合征冠状病毒 2:生物学和治疗选择。
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00187-20.
8
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
9
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.致命的冠状病毒:2003 年 SARS 大流行和 2020 年中国新型冠状病毒疫情。
J Autoimmun. 2020 May;109:102434. doi: 10.1016/j.jaut.2020.102434. Epub 2020 Mar 3.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.